These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 31982271

  • 1. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
    Huang HL, Lin WC, Yeh CC, Sun YT.
    J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
    [Abstract] [Full Text] [Related]

  • 2. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T, Cavazzana I, Ceruti P, Fredi M, Modina D, Berlendis M, Franceschini F.
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
    Xing X, Li A, Li C.
    Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
    [Abstract] [Full Text] [Related]

  • 6. The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease.
    Huang HL, Lin WC, Lin PY, Weng MY, Sun YT.
    Neurol Sci; 2021 Jul; 42(7):2855-2864. PubMed ID: 33211209
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J, Blank N, Max R, Lorenz HM, Wagner U, Krause D, Fiehn C.
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B.
    Immun Inflamm Dis; 2023 Nov; 11(11):e1085. PubMed ID: 38018600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
    Buvry C, Cassagnes L, Tekath M, Artigues M, Pereira B, Rieu V, Le Guenno G, Tournadre A, Ruivard M, Grobost V.
    Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
    [Abstract] [Full Text] [Related]

  • 14. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, Wang G.
    J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
    [Abstract] [Full Text] [Related]

  • 15. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.
    Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.
    Respir Med; 2014 Oct; 108(10):1542-8. PubMed ID: 25269710
    [Abstract] [Full Text] [Related]

  • 16. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
    Yamaguchi K, Tang Q, Poland P, Reay DP, Gregory A, Aggarwal R, Oddis CV, Ascherman DP.
    Front Immunol; 2024 Oct; 15():1399451. PubMed ID: 38895121
    [Abstract] [Full Text] [Related]

  • 17. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
    Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL, Childhood Myositis Heterogeneity Collaborative Study Group.
    Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
    [Abstract] [Full Text] [Related]

  • 18. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
    Li S, Sun Y, Shao C, Huang H, Wang Q, Xu K, Zhang X, Liu P, Zeng X, Xu Z.
    Rheumatology (Oxford); 2021 Mar 02; 60(3):1195-1204. PubMed ID: 32894294
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
    Liu Y, Liu X, Xie M, Chen Z, He J, Wang Z, Dai J, Cai H.
    Respir Med; 2020 Mar 02; 165():105920. PubMed ID: 32174452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.